老年人总、生物可利用及游离25(OH)D与骨健康指标的关系:一项随机对照试验
该研究为1年双盲随机对照试验的探索性分析,纳入221名>65岁超重且基线血清25(OH)D在10-30 ng/mL的参与者,随机接受钙和口服维生素D3(600 IU/天或3750 IU/天)。结果显示计算得到的游离和生物可利用25(OH)D在预测骨健康指标方面并不优于总25(OH)D。
要点
- 高剂量维生素D组所有维生素D变量水平较低剂量组高1.3-1.4倍(P<0.001)。
- 仅总25(OH)D与12个月股骨颈骨密度百分比变化呈正相关。
- 仅游离和生物可利用25(OH)D与12个月全身骨密度百分比变化呈正相关。
核心结论
- 在老年人群中,计算得到的游离和生物可利用25(OH)D在预测骨健康指标方面并不优于总25(OH)D。
研究设计与样本
- 一项为期1年、双盲、随机对照试验的探索性分析,于2014年7月完成;从3家大型医院的门诊招募参与者。
- 共221名>65岁、超重且基线血清25(OH)D在10-30 ng/mL的参与者完成研究。
- 参与者随机接受钙和口服维生素D3(600 IU/天或3750 IU/天)补充。
主要发现
- 接受较高维生素D剂量的参与者所有维生素D变量水平较低剂量组高1.3-1.4倍(P值<0.001)。
- 生物可利用和游离25(OH)D与总25(OH)D相关,r值分别为0.942和0.943(P值<0.001)。
- 甲状旁腺激素(PTH)与所有维生素D变量呈负相关,相关系数范围为-0.22至-0.25;钙和骨转换标志物(羧基端胶原交联和骨钙素)则无此关联。
- 仅总25(OH)D与12个月时股骨颈骨密度(BMD)百分比变化呈正相关。
- 仅游离和生物可利用25(OH)D与12个月时全身BMD百分比变化呈正相关。
临床怎么用
- 在老年超重人群中,总25(OH)D仍是评估维生素D状态与骨健康关系的可靠指标,计算游离或生物可利用25(OH)D未显示额外优势。
局限性
- 本研究为探索性分析,结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Questions regarding the superiority of free and bioavailable 25-hydroxyvitamin D [25(OH)D] in predicting health outcomes remain unresolved. OBJECTIVE: This study investigates the impact of vitamin D variables-total, bioavailable, or free 25(OH)D-on indices of bone and mineral metabolism, at baseline and in response to 2 vitamin D doses. DESIGN: Our objectives are implemented as exploratory analyses on data collected in a 1-year, double-blind, randomized controlled trial completed in July 2014. SETTING: Participants were recruited from 3 major hospitals in an ambulatory setting. PARTICIPANTS: Participants were >65 years of age, overweight, and had a baseline serum 25(OH)D between 10 and 30 ng/mL. A total of 221 participants completed the study. INTERVENTION: Subjects were randomized to receive calcium and oral vitamin D3 (600 IU/day or 3750 IU/day) supplementation. RESULTS: Participants who received the higher vitamin D dose had levels that were 1.3- to 1.4-fold higher than those taking the lower dose, for all variables (P value < 0.001). Serum values of bioavailable and free 25(OH)D were associated with total 25(OH)D, with r values of 0.942 and 0.943, respectively (P value < 0.001). Parathyroid hormone (PTH) was negatively associated with all vitamin D variables, with correlation coefficients ranging from -0.22 to -0.25, while calcium and bone turnover markers (carboxy-terminal collagen crosslinks and osteocalcin) did not. Only total 25(OH)D had a positive relationship with % change bone mineral density (BMD) at the femoral neck at 12 months, while only free and bioavailable 25(OH) had a positive relationship with % change total body BMD at 12 months. CONCLUSION: Calculated free and bioavailable 25(OH)D do not appear to be superior to total 25(OH)D in predicting indices of bone health in an elderly population.
引用
- El Sabeh M, Ghanem P, Al-Shaar L, et al. Total, Bioavailable, and Free 25(OH)D Relationship with Indices of Bone Health in Elderly: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2021. PMID: 33280041. doi:10.1210/clinem/dgaa780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。